Tufts Medical Center is recognized with an ‘A’ Rating in the Fall 2020 Leapfrog Hospital Safety Grade for meeting the highest patient safety standards.
Tufts Medical Center announced today that it has become the first center in New England to use the drug Jelmyto (UroGen Pharma, Inc.) for treatment of upper tract urothelial cancer (UTUC), a malignancy found in the kidney lining or the ureter, the thin tube connecting the bladder to the kidneys.
New England Comprehensive Stroke Center (CSC) Collaborative, created by Tufts Medical Center, is signing a pledge to continue providing care for stroke patients.
After more than 125 years of providing extraordinary care to sick and injured infants, children and teenagers, Floating Hospital for Children today takes on a new name - Tufts Children’s Hospital.
Tufts Medical Center is the first hospital in the country to partner with Medically Home as part of the response strategy, moving some patients from inpatient to in-home hospital-level care.